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Combinatorial biosynthesis was applied to Streptomyces deoxysugar biosynthesis genes in order to reconstitute
“unnatural natural gene clusters” for the biosynthesis of four D-deoxysugars (D-olivose, D-oliose, D-digitoxose, and
D-boivinose). Expression of these gene clusters in Streptomyces albus 16F4 was used to prove the functionality of the
designed clusters through the generation of glycosylated tetracenomycins. Three glycosylated tetracenomycins were
generated and characterized, two of which (D-digitoxosyl-tetracenomycin C and D-boivinosyl-tetracenocmycin C)
were novel compounds. The constructed gene clusters may be used to increase the capabilities of microorganisms
to synthesize new deoxysugars and therefore to produce new glycosylated bioactive compounds.
Microorganisms, mainly actinomycetes, produce a huge variety
of glycosylated compounds possessing biological activity, such as
antibiotics or antitumors. In the last few years, remarkable efforts
have been made to modify the sugar patterns of bioactive com-
pounds by using combinatorial biosynthesis approaches (22, 38,
39). This requires the use of sugar donor flexible glycosyltrans-
ferases and the ability to provide microorganisms with the capa-
bility to synthesize new sugars. However, the extension of these
studies is limited by the small variety of nucleotide diphosphate
(NDP) sugars that can be produced by a single strain.
The saccharide moieties of bioactive glycosylated compounds
are mainly deoxysugars. This is an important class of carbohy-
drates formed from common monosaccharides by replacement of
one or more hydroxyl groups with hydrogen. Among them, 2,6-
dideoxyhexoses (2,6-DOHs) are found ubiquitously in nature, but
they are especially abundant in antibiotic or antitumor com-
pounds, in which they play an important role in biological activity,
participating in the interaction with the cell targets. Most 2,6-
DOHs derive from glucose-1-phosphate, which is first activated to
dTDP (TDP)-D-glucose and then undergoes a 4,6 dehydration to
give rise to the common biosynthesis intermediate TDP-4-keto-
6-deoxy-D-glucose (19, 40). Next, C-2 deoxygenation takes place,
involving a dehydration step followed by a reduction reaction.
Two different products can arise from this C-2 deoxygenation
process, depending on the type of ketoreductase involved. When
a TylC1-like ketoreductase is involved, TDP-2,6-dideoxy-D-
glycero-D-glycero-4-hexulose is formed (7), whereas if a Gra-
Orf26-like protein participates, the product will be TDP-4-
keto-2,6-dideoxy-D-glucose (9). These two products differ only
in the configuration at the C-3 hydroxyl group, which is axial in
the former and equatorial in the latter. By further C-4 keto-
reduction or C-3,5 epimerization and C-4 ketoreduction steps
of these two biosynthesis intermediates, the different D- and
L-2,6-DOHs are generated (14, 29, 32).
Four possible 2,6-D-DOHs exist, differing in the configura-
tion of the hydroxyl groups at C-3 and C-4 (Fig. 1): D-olivose
(also known as D-canarose or D-chromose C), D-oliose, D-digi-
toxose, and D-boivinose. Of these, D-olivose is the most com-
monly found in bioactive compounds. However, D-oliose, and
especially D-digitoxose and D-boivinose, are quite unusual
among bioactive compounds produced by microorganisms.
Genes involved in the biosynthesis of D-olivose and D-oliose
have been identified from different antibiotic producer micro-
organisms (9, 13, 15, 16, 20, 24, 40, 42, 43). Very recently, a
gene cluster for the biosynthesis of D-digitoxose was also iden-
tified (5). However, no gene cluster involved in the biosynthe-
sis of D-boivinose has been identified so far. Here, we report
the use of combinatorial biosynthesis to reconstitute “unnatu-
ral natural gene clusters” for the biosynthesis of 2,6-D-DOH,
which can be used to provide Streptomyces species with the
capability to synthesize these four 2,6-D-DOHs. These DOH
gene clusters were expressed in a bifunctional (Escherichia
coli-Streptomyces) multicopy plasmid and were tested for the
generation of glycosylated compounds using the sugar flexible
glycosyltransferase ElmGT from the elloramycin cluster. Three
glycosylated tetracenomycin derivatives were generated, two of
which were new.
MATERIALS AND METHODS
Microorganisms, culture conditions, and vectors. Streptomyces griseus subsp.
griseus ATCC 13273 (a chromomycin producer) was used as the source of DNA.
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pFL942 and pFL943 (21) and pLN2 and pLNR (30) were used as sources of
sugar genes. Streptomyces lividans 16F4 (6) was used as the host for gene expres-
sion. Growth was carried out on trypticase soy broth (Oxoid) or R5A medium
(10) for product isolation. For sporulation, agar plates containing A medium (10)
were used, and cultures were grown for 7 days at 30°C. Escherichia coli DH10B
(Invitrogen) was used as a host for subcloning, and it was grown at 37°C in
trypticase soy broth medium. pCRBlunt (Invitrogen) and pUC18 were used as
vectors for subcloning experiments and DNA sequencing. pWHM3 (41) was used
for expressing genes in Streptomyces. When antibiotic selection of transformants
was needed, 50 g/ml of thiostrepton, 25 g/ml of apramycin, 50 g/ml of
kanamycin, or 100 g/ml of ampicillin was used.
DNA manipulation, PCR amplification, and sequencing. Plasmid DNA prep-
arations, restriction endonuclease digestions, alkaline phosphatase treatments,
ligations, and other DNA manipulations were performed according to standard
procedures for Streptomyces (17) and for E. coli (33). Specific oligoprimers were
used to amplify by PCR cmmUI (NMUI-U, 5-AAAAACTAGTGTGTCTGAG
FIG. 1. Proposed pathways for the biosynthesis of TDP-2,6-dideoxy-D-hexoses, showing the enzymes catalyzing the indicated biosynthetic steps.
In parentheses are enzymes with similar functions that were unable to carry out the corresponding reaction here.
TABLE 1. Plasmid constructs generated in this work
Plasmid Genes Characteristics
pMP3* mtmE, mtmD, oleV, oleW, urdR, oleY Derived from pLNR (30) and pFL942 (21)
pMP1*UI mtmE, mtmD, oleV, oleW, cmmUI, oleY pMP3* was digested with SpeI and NheI, and the urdR gene was replaced
by the cmmUI gene, flanked by the same restriction sites.
pMP1*UII mtmE, mtmD, oleV, oleW, cmmUII, oleY pMP3* was digested with SpeI and NheI, and the urdR gene was replaced
by the cmmUII gene, flanked by the same restriction sites.
pMP3*BII mtmE, mtmD, oleV, eryBII, urdR, oleY pMP3* was digested with HpaI and SpeI, and the oleW gene was replaced
by the eryBII gene, flanked by the same restriction sites.
pMP1*UIBII mtmE, mtmD, oleV, eryBII, cmmUI, oleY pMP1*UI was digested with HpaI and SpeI, and the oleW gene was
replaced by the eryBII gene, flanked by the same restriction sites.
pMP1*UIIBII mtmE, mtmD, oleV, eryBII, cmmUII, oleY pMP3*BII was digested with SpeI and NheI, and the urdR gene was
replaced by the cmmUII gene, flanked by the same restriction sites.
pMP1*BII mtmE, mtmD, oleV, eryBII, oleU, oleY pMP1*UIIBII was digested with SpeI and NheI, and the cmmUII gene
was replaced by the oleU gene, flanked by the same restriction sites.
pMP1*BIIU mtmE, mtmD, oleV, eryBII, oleY pMP1*BII was digested with SpeI and NheI and religated to delete
the oleU gene.
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AGGTGTCATG-3; NMUI-R, 5-AAAAGCTAGCTCAGGCGGAGGCCTC
GG-3) and cmmUII (NMUII-U, 5-AAAAACTAGTGCATAGGAGCCACAC
CATG-3; NMUII-R, 5-AAAAGCTAGCTCAAGCCGGACTCGAAGG-3).
The PCR conditions were as follows: 100 ng of template DNA was mixed with 30
pmol of each primer and 1.25 units of Platinum-Pfx DNA Polymerase (Invitro-
gene) in a total reaction volume of 50 l containing 1 mM MgSO4, 0.3 mM of
each deoxynucleoside triphosphate, 1 Pfx buffer, and, in some cases, PCRx
Enhancer Solution. The polymerization reactions were performed in a thermo-
cycler (PT-100; MJ Research). The general conditions for PCR amplification
were as follows: 2 min at 94°C; 30 cycles composed of 15 s at 94°C, 30 s at 55°C,
and 1 min at 68°C; 5 min at 68°C; and 15 min at 4°C. The PCR products were
purified with GFX PCR DNA and a Gel Band Purification Kit (Amersham
Biosciences), subcloned into pCRBlunt, and sequenced. Sequencing was per-
formed using the dideoxynucleotide chain terminator method (34) and the
Thermo Sequenase Labeled Primer Cycle Sequencing Kit with 7-deaza-dGTP
(Amersham Biosciences). Both DNA strands were sequenced with primers sup-
plied in the kits or with internal oligoprimers (18-mer) using an ALF-express
automatic DNA sequencer (Pharmacia). Computer-assisted database searching
and sequence analyses were carried out using the University of Wisconsin Ge-
netics Computer Group program package (8) and the BLAST program (4).
Plasmid constructs. For the construction of pMP3*, first the SphI-XbaI
polylinker fragment of pUC18 was used to replace the SphI-XbaI fragment in
pLNR (30) containing the oleL, oleS, and oleE genes. Then, from the resultant
construct, the 4.2-kb AvrII-XbaI fragment containing the oleV, oleW, urdR, and
oleY genes was used to replace the AvrII-XbaI fragment in pFL942 (21), gen-
erating pMP3*. In this final construct, oleV, oleW, urdR, and oleY are under the
control of ermE*p, and the mtmD and mtmE genes are divergently transcribed
from ermEp.
Several other constructs were made using pMP3* as the starting plasmid, as
shown in Table 1 and Fig. 2.
Production conditions and chromatographic techniques. Spores of S. lividans
16F4 containing the different constructs were grown in R5A medium under
conditions previously described (30). High-performance liquid chromatography
(HPLC) analyses were performed as previously described (30). Pure compounds
were used as standards for D-olivosyl-tetracenomycin C and 8-demethyl-tetra-
cenomycin C comparisons. They were purified from cultures of S. lividans strains
16F4 and 16F4(pLNR) (6, 30).
For the isolation of new glycosylated tetracenomycins, S. lividans strains
16F4(pMP3*BII) and 16F4(pMP1*BII) were cultured for 7 days in 2-liter
Erlenmeyer flasks with R5A medium, as previously described (27). In each case,
3.2 liters of culture was centrifuged, filtered, and extracted (10). The compounds
were purified by preparative HPLC, using a Bondapak C18 radial compression
cartridge (PrepPak Cartridge; 25 by 100 mm; Waters). An isocratic elution with
a mixture of acetonitrile and 0.1% trifluoroacetic acid in water (35:65) was used
in both cases. The peaks corresponding to the desired compounds were collected,
diluted fourfold with water, applied to a reverse-phase extraction cartridge,
washed with water to eliminate trifluoroacetic acid, and finally eluted with meth-
anol. After lyophilization, 7.9 mg of D-digitoxosyl-tetracenomycin C (DDIG-
TCMC) and 25.7 mg of D-boivinosyl-tetracenomycin C (DBOV-TCMC) were
obtained. HPLC-mass spectrometry (MS) analysis was carried out as previously
described (21).
NMR analysis. The nuclear magnetic resonance (NMR) data (Tables 2 and 3)
were recorded on a Varian Mercury 300 NMR spectrometer at a magnetic field
strength of 7.05 T.
RESULTS
In vivo reconstitution of gene clusters for the biosynthesis of
TDP-D-olivose and TDP-D-oliose. D-Olivose and D-oliose (Fig.
1) are both 2,6-D-DOHs with an equatorial C-3 hydroxyl group,
but they differ in the configuration of the hydroxyl group at
C-4: equatorial in the former and axial in the latter. D-Olivose
is present in several antibiotic and antitumor compounds, such
as mithramycin, chromomycin, urdamycin, and granaticin. D-
Oliose is more unusual, but it is also found in mithramycin and,
as a methylated or an acetylated derivative, in chromomycin
TABLE 2. 1H and 13C NMR data for DDIG-TCMC in
pyridine-d5 at 300 MHz
Carbon 1H NMR  (J in Hz) 13C NMR () Multiplicity
1 192.72 C
2 6.01 br s 101.37 CH
3 175.54 C
3-OCH3 3.56 (s) 57.06 OCH3
4 5.77 br s 71.74 CH
4a 87.55 C
5 195.71 C
5a 141.03 C
6 8.18 (s) 121.39 CH
6a 130.34 C
7 7.70 (s) 112.01 CH
8 156.08 C
9 130.08 C
9-CA O 168.59 C
9-CH3CO 4.01 53.15 CH3
10 138.54 C
10-CH3 2.89 (s) 21.71 CH3
10a 121.96 C
11 167.34 C
11-OH 14.03a br (s)
11a 110.67 C
12 199.70 C
12a 86.01 C
1 6.27 (dd, J  9, 3 Hz) 97.37 CH
2a 2.24 (ddd, J  13, 9, 3 Hz) 39.08 CH2
2e 2.60 (ddd, J  13, 3, 3 Hz)
3 4.56 (ddd, J  3, 3, 3 Hz) 72.20 CH
4 3.77 (dd, J  9, 3 Hz) 74.15 CH
5 4.62 (dd, J  9, 6 Hz) 68.42 CH
6 1.65 (d, J  6) 19.70 CH3
a Observable in d6-acetone.
TABLE 3. 1H and 13C NMR data for DBOV-TCMC in
pyridine-d5 at 300 MHz
Carbon 1H NMR  (J in Hz) 13C NMR () Multiplicity
1 192.76 C
2 6.02 br s 101.38 CH
3 175.57 C
3-OCH3 3.56 (s) 57.07 OCH3
4 5.79 br s 71.77 CH
4a 87.59 C
5 195.73 C
5a 141.07 C
6 8.20 (s) 121.39 CH
6a 130.30 C
7 7.74 (s) 112.02 CH
8 156.12 C
9 130.09 C
9-CA O 168.63 C
9-CH3CO 3.94 (s) 53.10 CH3
10 138.52 C
10-CH3 2.91 (s) 21.72 CH3
10a 121.94 C
11 167.37 C
11-OH 14.03a br (s)
11a 110.65 C
12 199.68 C
12a 86.02 C
1 6.28 (dd, J  9, 3 Hz) 98.08 CH
2a 2.80 (ddd, J  13, 9, 3 Hz) 35.29 CH2
2e 2.38 (ddd, J  13, 3, 3 Hz)
3 4.74 (ddd, J  3, 3, 3 Hz) 71.93 CH
4 4.00 (dd, J  3.0, 1.5) 71.77 CH
5 4.85 (dq, J  6.0, 1.5) 69.94 CH
6 1.66 (d, J  6.0) 18.03 CH3
a Observable in d6-acetone.
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A3. A gene cluster was constructed for the biosynthesis of
TDP-D-olivose in plasmid pWHM3, generating pMP3* (Fig.
2). This construct contained all the gene functions required to
synthesize TDP-D-olivose expressed under the control of two
divergent erythromycin resistance promoters, one controlling
the expression of two genes from the mithramycin gene cluster,
mtmD (TDP-D-glucose synthase) and mtmE (TDP–D-hexose-
4,6-dehydratase) (20), and the other controlling a set of four
genes, three of them from the oleandomycin gene cluster, oleV
(2,3-dehydratase), oleW (a 3-ketoreductase similar to Gra-
orf26), and oleY (O-methyltransferase) (3), and a 4-ketoreduc-
tase gene (urdR) from the urdamycin gene cluster (15). To
confirm that this gene cluster was able to direct the biosynthe-
sis of TDP-D-olivose, pMP3* was introduced into Streptomyces
lividans 16F4. This strain harbors cos16F4, a cosmid containing
part of the elloramycin biosynthetic gene cluster from Strepto-
myces olivaceus Tu¨2353, and its expression in streptomycete
hosts generates 8-demethyl-tetracenomycin C (8DMTC) (44)
(Fig. 3). This cosmid also contains a gene for the sugar flexible
glycosyltransferase ElmGT (6). Upon incubation of S. lividans
16F4(pMP3*) and analysis of cultures by HPLC-MS, in addi-
tion to the corresponding aglycone 8DMTC, a new peak (rep-
resenting approximately 35% of all tetracenomycins) was de-
tected (Fig. 4B). This peak was absent in a control experiment
using S. lividans 16F4(pWHM3) (Fig. 4A). The new compound
showed the same retention time as a pure sample of D-olivosyl-
tetracenomycin C (DOLV-TCMC) and m/z values of 459
(corresponding to the 8DMTC aglycone fragment) and 589
(corresponding to DOLV-TCMC). The formation of this
compound confirmed that pMP3* was directing the biosyn-
thesis of TDP-D-olivose.
The biosynthesis of TDP-D-oliose differs from that of TDP-
D-olivose only in the final ketoreduction step, which requires a
4-ketoreductase rendering a hydroxyl group at C-4 in axial
configuration. To construct a gene cluster for the biosynthesis
of TDP-D-oliose, it was necessary to replace the urdR gene
(coding for a 4-ketoreductase) with another one able of gen-
erating the hydroxyl group in axial configuration. Chromomy-
cin A3 contains both D-olivose and modified D-oliose moieties.
In the chromomycin cluster, there are two putative 4-ketore-
ductase genes that could be involved in the biosynthesis of
either D-olivose or D-oliose (24). These two genes, cmmUI and
cmmUII, were independently used to replace urdR in pMP3*,
generating pMP1*UI and pMP1*UII, respectively (Fig. 2).
Upon introduction of pMP1*UI into S. lividans 16F4, most
8DMTC was converted into DOLV-TCMC (Fig. 4C). The
formation of this compound confirmed that CmmUI is the
4-ketoreductase involved in D-olivose biosynthesis in the chro-
momycin pathway and pointed to CmmUII as the candidate
for the 4-ketoreductase in D-oliose biosynthesis. However,
when pMP1*UII was introduced into S. lividans 16F4, no
oliosyl-tetracenomycin or glycosylated tetracenomycin was ob-
served (data not shown). In order to prove the functionality of
pMP1*UII, i.e., its capability to direct the biosynthesis of D-
oliose, we expressed the plasmid in Streptomyces argillaceus
M7U1, a mithramycin nonproducer mutant in which D-oliose
biosynthesis is affected (13). Complementation of this mutant
was achieved, indicating that D-oliose biosynthesis was recov-
ered and therefore that genes in pMP1*UII were functional
(data not shown).
In vivo reconstitution of gene clusters for the biosynthesis of
TDP-D-digitoxose and TDP-D-boivinose and generation of
novel glycosylated derivatives of tetracenomycin C. D-Digitox-
ose and D-boivinose are both 2,6-D-DOHs with an axial C-3
hydroxyl group, but they differ in the configuration of the
hydroxyl group at C-4: equatorial in the former and axial in the
latter (Fig. 1). D-Digitoxose is well known as a constituent of
plant cardiac and other steroidal glycosides (1, 2). D-Boivinose
is an unusual DOH. As far as we know, it has been described
only as a component of two flavone C-glycosides from Zea
mays with glycation-inhibitory activities (37). As a constituent
of antibiotic or antitumour compounds, D-digitoxose is present
in the apoptosis inducer ammocidin produced by Saccharothrix
sp. (25) and in the antibacterial saccharomicin produced by
Saccharotrix espanaensis (18, 35). Very recently, a gene cluster
for the biosynthesis of TDP-D-digitoxose was identified (5).
However, no gene cluster for the biosynthesis of TDP-D-boivi-
nose has been identified in antibiotic-producing microorgan-
isms. We anticipated that a pathway for the biosynthesis of
2,6-D-DOH with a hydroxyl group at C-3 in axial configuration
would require the same enzymatic steps needed to synthesize
D-olivose and D-oliose but involving a TylC1-like ketoreductase
to render the sugar intermediate TDP-2,6-dideoxy-D-glycero-D-
glycero-4-hexulose (Fig. 1). Consequently, we decided to test
this hypothesis.
D-Olivose differs from D-digitoxose only in the stereochem-
istry at C-3 (Fig. 1). To construct a gene cluster for the bio-
synthesis of TDP-D-digitoxose, we used as starting plasmids
pMP3* and pMP1*UI, which direct the biosynthesis of D-
olivose. We replaced in these plasmids the oleW 3-ketoreduc-
tase gene with the TylC1-homologous 3-ketoreductase gene
eryBII (12, 36), generating pMP3*BII and pMP1*UIBII, re-
spectively (Fig. 2). After expressing pMP1*UIBII in S. lividans
16F4, only a peak corresponding to 8DMTC was observed
(data not shown). However, when pMP3*BII was used, ap-
FIG. 3. Chemical structures of glycosylated tetracenomycin deriv-
atives.
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proximately 55% of the aglycone 8DMTC was converted into
a novel compound eluting at 17.0 min (Fig. 4D). The com-
pound in this peak showed an m/z value in positive mode of 589
(with a fragmentation ion of m/z 459, corresponding to
8DMTC). This compound was purified, and NMR analysis
(see below) confirmed that it corresponded to the novel com-
pound DDIG-TCMC (Fig. 3). The formation of this com-
pound confirmed that pMP3*BII was directing the biosynthesis
of TDP-D-digitoxose. These results also indicated that, as has
been reported (15, 28), the UrdR 4-ketoreductase shows a
certain degree of substrate flexibility and can be used to gen-
erate 2,3,6-trideoxyhexoses and 2,6-dideoxyhexoses with differ-
ent stereochemistries at C-3. On the other hand, the 4-ketore-
ductase CmmUI shows low substrate flexibility, since it is not
able to act on a substrate differing from its natural one in the
stereochemistry at C-3.
To construct a gene cluster for the biosynthesis of TDP-D-
boivinose, it was necessary to incorporate, in addition to eryBII,
a gene coding for a 4-ketoreductase that would render a hy-
droxyl group in axial configuration. We therefore replaced in
pMP3*BII the 4-ketoreductase urdR gene (which renders hy-
droxyl groups in equatorial configuration) with the cmmUII
gene. The resultant plasmid pMP1*UIIBII was expressed in S.
lividans 16F4, but no glycosylated tetracenomycin was detected
(data not shown). This suggested that, similarly to CmmUI, the
CmmUII ketoreductase was unable to act on the substrate
TDP-2,6-dideoxy-D-glycero-D-glycero-4-hexulose, which has ste-
reochemistry at C-3 opposite to that of its normal substrate.
Alternatively, the possibility exists that ElmGT is unable to
transfer D-boivinose. To clarify this situation, we decided to use
a different 4-ketoreductase, OleU, which is involved in the
biosynthesis of L-oleandrose in the oleandomycin pathway (3).
A first indication that OleU could be suitable for the biosyn-
thesis of D-boivinose arose from the analysis of cultures of S.
lividans 16F4 expressing pFL1012 (21). This plasmid derives
from pFL943, which has been shown to direct the biosynthesis
of TDP-L-olivose and TDP-L-rhamnose. pFL1012 contains the
same gene functions as pFL943, but it lacks the oleL 3,5-
epimerase gene, which prevents it from directing the bio-
synthesis of L-DOH (21). Notably, cultures of S. lividans
16F4(pFL1012) produced a glycosylated tetracenomycin with
the same mass as DOLV-TCMC or DDIG-TCMC but showing
a different retention time. This result prompted us to think that
this compound could correspond to DBOV-TCMC. Conse-
quently, we used the oleU 4-ketoreductase to replace cmmUII
in pMP1*UIIBII. Upon transforming S. lividans 16F4 with the
resultant construct, pMP1*BII (Fig. 2), a major peak (repre-
senting 76% of all tetracenomycins) was detected (Fig. 4E),
eluting at 16.2 min and showing an m/z value of 589 (with a
fragmentation ion of m/z 459, corresponding to 8DMTC). This
mass was in accordance with the presence of a 2,6-DOH at-
tached to 8DMTC. The compound from this peak was purified,
and NMR analysis (see below) revealed that it corresponded to
the novel compound DBOV-TCMC (Fig. 3). The formation of
this compound confirmed that pMP1*BII was directing the
biosynthesis of TDP-D-boivinose. To eliminate the possibility
that a 4-ketoreductase gene from the S. lividans 16F4 host
strain was participating in the biosynthesis of D-boivinose, a
control experiment was run using pMP1*BIIU, a derivative
of pMP1*BII in which oleU was deleted. Using this construct,
no DBOV-TCMC was detected, confirming that OleU was the
4-ketoreductase involved in the formation of this boivinosyl
derivative. This result also indicated that OleU shows a certain
degree of flexibility, since, although it normally reduces a 2,6-
L-DOH intermediate, it can also act on a 2,6-D-DOH substrate.
Structure elucidation of D-digitoxosyl-tetracenomycin C and
D-boivinosyl-tetracenomycin C. The two novel tetracenomycins
were characterized by liquid chromatography-MS (see below)
and NMR spectroscopy in comparison with various previously
described 8-position glycosylated tetracenomycins and ellora-
mycins (11, 31, 44).
The positive atmospheric pressure chemical ionization (APCI)
mass spectrum of DDIG-TCMC showed two major mass frag-
ments, at m/z 589 (M) and at m/z 459 (M-sugar). While the
former confirms the deduced molecular formula of C28H28O14,
the latter is consistent with the fragment obtained from the
aglycon after cleavage of a 2,6-DOH unit. This pattern of M
and M-sugar fragmentations is typical of the glycosylated tet-
racenomycins and elloramycins. The 1H NMR data (Table 2)
revealed a -glycosidically bound D-sugar (deduced from the
large coupling of 1-H of 9 Hz), as well as a sugar in 4C1
conformation typical of D-sugars (from the overall H-H cou-
pling pattern observed in the sugar unit, particularly the two
axial protons in the 1	 and 5 positions). The observed stereo-
chemistry at the 3 position (a multiple resulting from three
small 3JH-H couplings with neighboring protons reveals an ax-
ially attached OH group) and in the 4 position (dd, J  9, 3
Hz, revealing an equatorially attached OH group) is consistent
with digitoxose stereochemistry. This suggests the structure of
8-demethyl-8--D-digitoxosyltetracenomycin C for DDIG-
TCMC, which was fully confirmed by the 13C NMR data (Ta-
ble 2).
The positive APCI mass spectrum of DBOV-TCMC gave
the same molecular formula (C28H28O14) and major fragmen-
tation (M at m/z 589; M-sugar at m/z 459) found for DDIG-
TCMC, also consistent with a tetracenomycin derivative with a
2,6-dideoxysugar attached in the 8 position (for the APCI mass
spectrum and the major fragmentation in the APCI mass spec-
trum, see the supplemental material). The 1H NMR spectrum
(Table 3) revealed the difference from DDIG-TCMC. While
we also observed a -glycosidically bound D-sugar in 4C1 con-
formation, the signals of 3-H ( 4.74, ddd, J 3.0, 3.0, 3.0 Hz)
and 4-H ( 4.00, dq, J  6.0, 1.5 Hz) of the sugar moiety
clearly show that the OH groups in these two positions are
attached axially in both cases, which gives rise to a boivinose
stereochemistry. Therefore, the structure of 8-demethyl-8--D-
boivinosyl-tetracenomycin C could be deduced for DBOV-
TCMC. This was fully confirmed by the 13C NMR data (Table 3).
DISCUSSION
Many bioactive compounds produced by actinomycetes are
glycosylated, and in many cases, the saccharide moieties are
essential for bioactivity. Therefore, efforts to modify the gly-
cosylation pattern of a certain compound could have practical
implications, since they could lead to the generation of a more
active compound or one with improved pharmacological char-
acteristics. This type of modification can be approached by
combinatorial biosynthesis, providing that flexible glycosyl-
transferases exist, together with the possibility of using differ-
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ent nucleotide DOHs. In this context, the isolation of natural
gene clusters and the reconstitution of “unnatural gene clus-
ters” for the biosynthesis of DOHs have allowed their use for
the generation of new glycosylated compounds (23, 26, 38). In
this study, we have reconstituted “unnatural natural gene clus-
ters” for the biosynthesis of four different activated 2,6-D-
DOHs, namely, TDP-D-olivose, TDP-D-oliose, TDP-D-digitox-
ose, and TDP-D-boivinose. To achieve this, we combined, in a
rational way, the required genes involved in sugar biosynthesis
from different antibiotic and antitumor biosynthetic gene clus-
ters: the antitumor agents mithramycin, chromomycin, and
urdamycin and the antibiotics oleandomycin and erythromycin.
Since the biosynthesis of 2,6-D-DOH proceeds through three
common initial steps, all the gene clusters constructed contain
three genes, which code for the enzymatic activities involved in
those steps: the glucose synthase gene mtmD and the 4,6-
dehydratase gene mtmE from the mithramycin cluster (20) and
the 3,4-dehydratase gene oleV from the oleandomycin cluster
(3), whose enzymatic activities had already been proven in
vitro (20) or in vivo (30). In addition, gene clusters for the
biosynthesis of TDP-D-olivose and TDP-D-oliose include the
3-ketoreductase gene oleW from the oleandomycin gene clus-
ter, which had been shown to be involved in L-olivose biosyn-
thesis reducing the keto group at C-3 with the formation of a
hydroxyl group in equatorial configuration (3, 30). On the
other hand, gene clusters for the biosynthesis of TDP-D-digi-
toxose and TDP-D-boivinose contain the eryBII C-3 ketore-
ductase from the erythromycin gene cluster, involved in
L-mycarose biosynthesis (12, 36). Previous experiments have
suggested that EryBII was able to introduce hydroxyl groups at
C-3 in axial configuration (21). The fact that pMP3*BII and
pMP1*BII were able to direct the biosynthesis of TDP-D-digi-
toxose and TDP-D-boivinose, respectively, confirms that func-
tion for EryBII and also indicates that this process takes place
on a nucleotide sugar intermediate of D configuration.
All 2,6-D-DOH gene clusters contain a 4-ketoreductase
gene. Thus, those for the biosynthesis of TDP-D-olivose and
TDP-D-digitoxose (with hydroxyl groups at C-4 in equatorial
configuration) include the 4-ketoreductase gene urdR from the
urdamycin cluster, which has been shown to code for a 4-ke-
toreductase in D-olivose biosynthesis (15, 30). A gene cluster
(present in pMP1*UI) for the biosynthesis of TDP-D-olivose
was also constructed using a different 4-ketoreductase gene,
cmmUI, a gene from the chromomycin gene cluster, which was
proposed to code for a 4-ketoreductase involved in sugar bio-
synthesis (24). The fact that pMP1*UI directed the biosynthe-
sis of D-olivose demonstrates that CmmUI is the 4-ketoreduc-
tase for D-olivose biosynthesis in the chromomycin pathway.
On the other hand, in the gene cluster for the biosynthesis of
TDP-D-boivinose, we included the oleU gene from the olean-
domycin gene cluster, which has been shown to be involved in
the biosynthesis of L-olivose (3). The fact that OleU can also be
used for the biosynthesis of D-boivinose indicates that OleU
shows some substrate flexibility, since although its natural sub-
strate is a nucleotide sugar intermediate in L configuration, the
results obtained demonstrate that OleU is also able to act on
D-DOH biosynthesis intermediates. Finally, the gene cluster
for the biosynthesis of TDP-D-oliose (present in pMP1*UII)
includes the 4-ketoreductase cmmUII from the chromomycin
gene cluster.
Validation of the functionality of the described gene clusters
was achieved by expressing them in Streptomyces albus 16F4
and the subsequent formation of the corresponding glyco-
sylated tetracenomycin. However, when plasmid pMP1*UII
was used, no glycosylated tetracenomycin was produced. Two
possible hypotheses exist to explain this result: (i) CmmUII is
not the 4-ketoreductase for TDP-D-oliose and therefore
pMP1*UII is not able to direct the biosynthesis of this deoxy-
sugar, and consequently no glycosylated tetracenomycin is
formed, or (ii) even though the biosynthesis of TDP-D-oliose is
directed by pMP1*UII, the possibility exists that this DOH was
not recognized by the ElmGT glycosyltransferase. We favor
the second explanation, since pMP1*UII directs the biosynthe-
sis of D-oliose, as it was able to complement the non-mithra-
mycin-producing mutant S. argilllaceus M7U1, in which D-oliose
biosynthesis is affected. Moreover, previous experiments also
suggested that the glycosyltransferase ElmGT was not able to
recognize TDP-D-oliose as a substrate. Thus, it has been shown
that by expressing cosmid 16F4 in the mithramycin producer S.
argillaceus, no D-oliosyl-tetracenomycin C was obtained, de-
spite the fact that this microorganism synthesizes TDP-D-oliose
(44).
In this work, two novel glycosylated tetracenomycins were
generated, DDIG-TCMC and DBOV-TCMC. The formation
of these two new compounds extends the NDP-sugar donor
substrate profile usable by the ElmGT glycosyltransferase by
two. ElmGT has been previously shown to be able to transfer
nine different sugars (23).
Gene clusters for the biosynthesis of TDP-D-boivinose in
antibiotic producers had not been described or isolated previ-
ously. The reconstituted gene clusters described here for the
biosynthesis of this DOH, and also those for TDP-D-digitox-
ose, TDP-D-olivose, and TDP-D-oliose, will be very useful for
the generation of new glycosylated derivatives of bioactive
compounds by providing host strains with the capability of
synthesizing these D-DOHs, which then could be potentially
transferred by existing glycosyltransferases of the host to an
aglycone. In addition, the information obtained from the re-
constituted gene clusters for the biosynthesis of TDP-D-boivi-
nose could help to predict which gene functions should be
present in a natural gene cluster for this deoxysugar.
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